<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04882657</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-COL-2019-64</org_study_id>
    <nct_id>NCT04882657</nct_id>
  </id_info>
  <brief_title>Collateral Circulation in Acute Ischemic Stroke With Large Vessel Occlusion</brief_title>
  <acronym>COLISEUM</acronym>
  <official_title>Collateral Circulation (&quot;Collaterome&quot;) in Acute Ischemic Stroke With Large Vessel Occlusion: A Study of Clinical, Radiological, Plasma and Genetic Factors.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Complejo Hospitalario Universitario de Albacete</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital de Cruces</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Clínico Universitario de Valladolid</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospitales Universitarios Virgen del Rocío</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundación de Investigación Biomédica - Hospital Universitario de La Princesa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario La Paz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital del Mar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Arnau de Vilanova</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Complexo Hospitalario Universitario de A Coruña</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Red de Enfermedades Vasculares Cerebrales INVICTUS PLUS (Rd1600190024)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective multicenter study of consecutive patients with acute ischemic stroke and large&#xD;
      intracranial vessel occlusion in which a thorough and systematic evaluation of all variables&#xD;
      that may be related to the degree of collateral circulation is performed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction. In patients with an acute ischemic stroke due to a large-vessel intracranial&#xD;
      occlusion (LVO), the status of the colateral circulation (CC) is related to clinical outcome&#xD;
      and to the success of mechanical thrombectomy. However, CC is highly variable from patient to&#xD;
      patient.&#xD;
&#xD;
      Methods. An observational, prospective, multicenter study of 700 consecutive patients with&#xD;
      acute ischemic stroke and a LVO. Factors to be evaluated: 1) Modifiable: Vascular risk&#xD;
      factors, blood analysis, prior medications, vital constants (with emphasis on continuous&#xD;
      blood pressure monitoring), head position, metrics (time to admission, Computed tomography&#xD;
      (CT), groin puncture, end of procedure), 2) Non-modifiable: age, sex, completeness of Circle&#xD;
      of Willis, etiology, type of mechanical thrombectomy, plasma biomarkers, genetic/epigenetic&#xD;
      factors (a discovery phase with GWAs study and a replication phase). CC grade will be&#xD;
      assessed by the ASITN/SIR collateral score from CT-angiography (CTA) and the Digital&#xD;
      substraction angiography (DSA, when performed). Statistics: bivariate analyses and a logistic&#xD;
      regression to predict CC grade (poor versus good) and CC persistence comparing CTA with DSA&#xD;
      (4 possibilities: poor-poor, poor-good, good-poor, good-good).&#xD;
&#xD;
      Expected results. Our study may find markers of the CC status, facilitate the design of&#xD;
      clinical trials to improve CC grade, may find new therapeutic targets and new treatments to&#xD;
      enhance the beneficial effects of mechanical thrombectomy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Collateral Circulation grade</measure>
    <time_frame>Trough the acute phase of stroke, an average of 24 hours</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Stroke, Ischemic</condition>
  <condition>Stroke, Acute</condition>
  <condition>Collateral Circulation, Any Site</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sampling will be obtained by venipuncture in EDTA tubes at admission and processed at&#xD;
      each center. Samples will be sent to the promoter site for genetic and plasma markers&#xD;
      analysis.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute ischemic stroke and a large-vessel intracranial occlusion.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with acute ischemic stroke.&#xD;
&#xD;
          -  Large vessel occlusion of an intracranial internal artery: M1, M2 or TICA. (terminal&#xD;
             intracranial carotid artery), as demonstrated by CTA.&#xD;
&#xD;
          -  CTA performed within the first 24 hours after stroke onset. Patients with wake-up&#xD;
             stroke are included.&#xD;
&#xD;
          -  A previous modified Rankin Scale score of 0 to 3.&#xD;
&#xD;
          -  The patient or a legal representative signs a written consent to participate.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  More than 24 hours from last been known to be well.&#xD;
&#xD;
          -  Occlusion of other arterial segments (vertebrobasilar circulation, A1, P1, M3, M4).&#xD;
&#xD;
          -  Age below 18 years.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Joan Martí-Fàbregas, MD, PhD</last_name>
    <phone>+34935565986</phone>
    <email>jmarti@santpau.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daniel Guisado-Alonso, MD</last_name>
    <phone>+34935565986</phone>
    <email>dguisado@santpau.cat</email>
  </overall_contact_backup>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>December 5, 2019</study_first_submitted>
  <study_first_submitted_qc>May 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2021</study_first_posted>
  <last_update_submitted>May 11, 2021</last_update_submitted>
  <last_update_submitted_qc>May 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Collateral Circulation</keyword>
  <keyword>Ischemic Stroke</keyword>
  <keyword>Large Vessel Occlusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

